LFMDP LifeMD, Inc. - 8.875% Series A Cumulative Perpetual Preferred Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ 10-K/10-Q Aug 5, 2026LFMDP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
LFMDP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LFMDP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 127.9 | · | 3.0 | Overvalued | |
| Price / Tangible Book (MRQ) | 131.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LFMDP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.9 | · | 2.3 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Oct 2, 2026 | $0.56 | USD | ≈9.8% |
| Jul 2, 2026 | $0.56 | USD | ≈9.5% |
| Apr 2, 2026 | $0.56 | USD | ≈9.6% |
| Jan 5, 2026 | $0.56 | USD | ≈9.7% |
| Oct 3, 2025 | $0.56 | USD | ≈9.4% |
| Jul 3, 2025 | $0.56 | USD | ≈9.2% |
| Apr 4, 2025 | $0.56 | USD | ≈9.7% |
| Jan 3, 2025 | $0.56 | USD | ≈9.9% |
| Oct 4, 2024 | $0.56 | USD | ≈10.0% |
| Jul 5, 2024 | $0.56 | USD | ≈9.7% |
| Apr 4, 2024 | $0.56 | USD | ≈9.9% |
| Jan 4, 2024 | $0.56 | USD | ≈12.4% |
| Oct 5, 2023 | $0.56 | USD | ≈11.8% |
| Jul 6, 2023 | $0.56 | USD | ≈11.7% |
| Apr 5, 2023 | $0.56 | USD | ≈15.4% |
| Jan 5, 2023 | $0.56 | USD | ≈16.0% |
| Oct 6, 2022 | $0.56 | USD | ≈16.5% |
| Jul 1, 2022 | $0.56 | USD | ≈12.4% |
| Apr 4, 2022 | $0.56 | USD | ≈6.5% |
| Jan 3, 2022 | $0.62 | USD | ≈3.4% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.16 | $-0.15 | -7.7% | |
| March 31, 2026 | $-0.20 | $-0.23 | 11.7% | |
| Dec. 31, 2025 | $-0.04 | $-0.03 | -17.6% | |
| Sept. 30, 2025 | $-0.07 | $-0.05 | -47.1% | |
| June 30, 2025 | $-0.06 | $-0.01 | — | |
| March 31, 2025 | $0.01 | $-0.05 | 118.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue | $47M | $49M | |
| Cost of Revenue | $5M | $7M | |
| Gross Profit | $42M | $42M | |
| SG&A Expense | $14M | $14M | |
| Operating Expenses | $49M | $45M | |
| Operating Income | $-7M | $-2M | |
| Interest Expense | $-45.7K | $660.8K | |
| Pretax Income | $-7M | $-3M | |
| Net Income | $-7M | $-2M | |
| EPS (Basic) | $-0.16 | $-0.05 | |
| EPS (Diluted) | $-0.16 | $-0.05 | |
| Shares (Basic) | 47,788,194 | 44,401,531 | |
| Shares (Diluted) | 47,788,194 | 44,401,531 | |
| EBITDA | $-7M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Cash & Equivalents | $25M | · | |
| Receivables | $11M | · | |
| Inventory | $3M | · | |
| Other Current Assets | $2M | · | |
| Current Assets | $42M | · | |
| PP&E (Net) | $2M | · | |
| PP&E (Gross) | $4M | · | |
| Accum. Depreciation | $2M | · | |
| Intangibles | $198.5K | · | |
| Total Assets | $60M | · | |
| Accounts Payable | $18M | · | |
| Accrued Liabilities | $17M | · | |
| Current Liabilities | $47M | · | |
| Capital Leases | $5M | · | |
| Total Liabilities | $52M | · | |
| Common Stock | $479.2K | · | |
| Paid-in Capital | $254M | · | |
| Retained Earnings | $-246M | · | |
| Treasury Stock | $163.7K | · | |
| Stockholders' Equity | $8M | · | |
| Liabilities + Equity | $60M | · | |
| Shares Outstanding | 47,820,492 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Stock-based Comp | $790.1K | · | |
| Amort. of Intangibles | $32.0K | $23.0K | |
| Operating Cash Flow | $-7M | · | |
| CapEx | $67.8K | · | |
| Investing Cash Flow | $-2M | · | |
| Dividends Paid | $776.6K | · | |
| Financing Cash Flow | $-776.6K | · | |
| Net Change in Cash | $-9M | · | |
| Taxes Paid | · | $445.2K |
Profitability
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Gross Margin | 88.8% | · | |
| Operating Margin | -15.1% | · | |
| Net Margin | -15.0% | · | |
| Pretax Margin | -15.0% | · | |
| EBITDA Margin | -15.1% | · | |
| ROA | -10.6% | · | |
| ROE | -229.1% | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Current Ratio | 0.9 | · | |
| Quick Ratio | 0.8 | · | |
| Interest Coverage | 156.1 | · |
Efficiency
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Asset Turnover | 0.7 | · | |
| Inventory Turnover | 1.7 | · | |
| Receivables Turnover | 5.1 | · |
Per Share
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Book Value / Share | $0.17 | · | |
| Revenue / Share | $0.99 | · | |
| Cash / Share | $0.53 | · | |
| EPS (TTM) | · | $-0.34 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q2 2025 |
|---|---|---|---|
| Revenue TTM | $165M | $160M | |
| Net Income TTM | $201.0K | $-10M | |
| Market Cap | $1.12B | · | |
| P/E | · | -71.1 | |
| P/S | 6.8 | 6.8 | |
| P/B | 141.1 | · | |
| P / Tangible Book | 144.7 | · | |
| Dividend Yield | 0.28% | 0.29% | |
| Earnings Yield | · | -1.4% | |
| Annual Payout | $3M | $3M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Company insiders 6 insiders · 0 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Joan Larovere | Director | Aug. 11, 2026 A | 142,050 | 0 | 0 | $0 |
| John R Strawn Jr | Director | Aug. 11, 2026 A | 498,001 | 0 | 0 | $0 |
| Calum Archibald Macrae | · | Aug. 11, 2026 A | 73,865 | 0 | 0 | $0 |
| Joseph Ditrolio | · | Aug. 11, 2026 A | 308,413 | 0 | 0 | $0 |
| Roberto Simon | · | Aug. 11, 2026 A | 288,175 | 0 | 0 | $0 |
| Umesh Sripad | · | June 1, 2026 A | 75,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
LFMDP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LFMDP | · | · | · | · | · | · |
| AMWL | $81M | -0.8 | -2.0% | -38.4% | -35.4% | · |
| OPRX | $230M | 45.4 | 18.8% | 4.7% | 4.2% | 67.2% |
| DH | · | -2.2 | -4.2% | -57.5% | -28.2% | 75.9% |
| HCAT | · | -0.9 | 1.5% | · | · | · |
| LFMD | $159M | 13.6 | 25.3% | 7.4% | 204.0% | 85.7% |
| CCLD | · | · | · | · | · | · |
| DRIO | $79M | 1.1 | -17.3% | -186.6% | -63.2% | 56.6% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.